ATE257834T1 - Heterocyclische aminopyrrolidon-derivate als melatonergene wirkstoffe - Google Patents

Heterocyclische aminopyrrolidon-derivate als melatonergene wirkstoffe

Info

Publication number
ATE257834T1
ATE257834T1 AT00938160T AT00938160T ATE257834T1 AT E257834 T1 ATE257834 T1 AT E257834T1 AT 00938160 T AT00938160 T AT 00938160T AT 00938160 T AT00938160 T AT 00938160T AT E257834 T1 ATE257834 T1 AT E257834T1
Authority
AT
Austria
Prior art keywords
heterocyclic
melatonergenic
actives
aminopyrrolidone derivatives
aminopyrrolidone
Prior art date
Application number
AT00938160T
Other languages
English (en)
Inventor
Katherine S Takaki
Guanglin Luo
Stephen R Bertenshaw
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE257834T1 publication Critical patent/ATE257834T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Cosmetics (AREA)
AT00938160T 1999-06-30 2000-06-06 Heterocyclische aminopyrrolidon-derivate als melatonergene wirkstoffe ATE257834T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14189499P 1999-06-30 1999-06-30
PCT/US2000/015478 WO2001002392A1 (en) 1999-06-30 2000-06-06 Heterocyclic aminopyrrolidine derivatives as melatonergic agents

Publications (1)

Publication Number Publication Date
ATE257834T1 true ATE257834T1 (de) 2004-01-15

Family

ID=22497702

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00938160T ATE257834T1 (de) 1999-06-30 2000-06-06 Heterocyclische aminopyrrolidon-derivate als melatonergene wirkstoffe

Country Status (13)

Country Link
US (1) US6211225B1 (de)
EP (1) EP1189900B1 (de)
JP (2) JP4767463B2 (de)
AT (1) ATE257834T1 (de)
AU (1) AU763963B2 (de)
CA (1) CA2376949C (de)
DE (1) DE60007745T2 (de)
DK (1) DK1189900T3 (de)
ES (1) ES2213022T3 (de)
PE (1) PE20010327A1 (de)
PT (1) PT1189900E (de)
UY (1) UY26226A1 (de)
WO (1) WO2001002392A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2619691B2 (ja) 1988-06-21 1997-06-11 京セラ株式会社 糸 道
US6569894B1 (en) 2001-10-04 2003-05-27 Bristol-Myers Squibb Company Arylalkylbenzofuran derivatives as melatonergic agents
US6737431B2 (en) 2002-03-12 2004-05-18 Bristol-Myers Squibb Company Benzoxazole derivatives as novel melatonergic agents
MXPA05001631A (es) 2002-08-12 2005-08-19 Takeda Pharmaceutical Derivado de benceno fusionado y su uso.
AU2006239942A1 (en) * 2005-04-22 2006-11-02 Wyeth Dihydrobenzofuran derivatives and uses thereof
GT200600167A (es) * 2005-04-22 2007-03-14 Derivados de dihidrobenzofurano y usos de los mismos
AU2007253704A1 (en) 2006-05-22 2007-11-29 Vanda Pharmaceuticals, Inc. Treatment for depressive disorders
EP2141150B1 (de) * 2007-04-26 2013-12-11 Takeda Pharmaceutical Company Limited Bicyclische verbindung und ihre pharmazeutische verwendung
ES2331276B1 (es) * 2007-10-25 2010-10-21 Ferrer Internacional, S.A. Compuestos de fenilpirrolidina.
EP2266975A1 (de) * 2009-06-15 2010-12-29 Ferrer Internacional, S.A. 1-(2-Alkyl-2,3-dihydrobenzofuran-4-yl)pyrrolidin-3-ylaminacyl-Verbindungen
CA3085116C (en) 2012-01-26 2022-07-19 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
ES2681593T3 (es) 2012-11-29 2018-09-14 Chemocentryx, Inc. Antagonistas de CXCR7
KR102148990B1 (ko) 2012-12-18 2020-08-27 반다 파마슈티칼즈, 인코퍼레이티드. 일주기 리듬 장애의 치료
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
BR102016024814A2 (pt) 2016-10-24 2018-05-08 Aché Laboratórios Farmacêuticos S.A. composto, processo de obtenção do composto, composição farmacêutica, uso do composto e método de tratamento de desordens psiquiátricas e/ou distúrbios do sono
MA54465A (fr) 2018-12-12 2021-10-20 Chemocentryx Inc Inhibiteurs de cxcr7 destinés au traitement du cancer
CN109574970A (zh) * 2018-12-27 2019-04-05 上海毕得医药技术有限公司 一种5-溴苯并二氢吡喃的合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3518273A (en) * 1966-08-03 1970-06-30 Warner Lambert Pharmaceutical Benzopyranquinolinol derivatives and process for their production
US3485835A (en) * 1968-04-10 1969-12-23 Haessle Ab 2-benzoyl-3-tertiaryamino alkoxy benzofuran derivatives
US5071875A (en) 1989-09-25 1991-12-10 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
FR2674524B1 (fr) 1991-03-25 1993-05-21 Adir Nouveaux amides alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2680366B1 (fr) 1991-08-13 1995-01-20 Adir Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
FR2689124A1 (fr) 1992-03-27 1993-10-01 Adir Nouvelles naphtylalkylamines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US5449683A (en) 1992-10-01 1995-09-12 Massachussetts Institute Of Technology Methods of inducing sleep using melatonin
GB9326192D0 (en) 1993-12-22 1994-02-23 Glaxo Group Ltd Chemical compounds
GB9407919D0 (en) 1994-04-21 1994-06-15 Glaxo Group Ltd Chemical compounds
FR2725985B1 (fr) 1994-10-21 1996-11-15 Adir Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5753709A (en) * 1995-06-07 1998-05-19 Bristol-Myers Squibb Company N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
CA2253802A1 (en) 1996-05-14 1997-11-20 Peter Charles North Benzofurans and benzopyrans as chronobiological agents
RU2190609C2 (ru) * 1996-12-10 2002-10-10 Бристол-Маерс Сквибб Компани Производные бензодиоксола, бензофурана, дигидробензофурана и бензодиоксана и содержащие их композиции
FR2761358B1 (fr) * 1997-03-27 1999-05-07 Adir Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
JP2011137043A (ja) 2011-07-14
JP4767463B2 (ja) 2011-09-07
US6211225B1 (en) 2001-04-03
CA2376949C (en) 2009-05-26
EP1189900A1 (de) 2002-03-27
AU5324000A (en) 2001-01-22
PE20010327A1 (es) 2001-06-10
DE60007745D1 (de) 2004-02-19
ES2213022T3 (es) 2004-08-16
JP2003503492A (ja) 2003-01-28
PT1189900E (pt) 2004-05-31
AU763963B2 (en) 2003-08-07
EP1189900A4 (de) 2002-07-31
DK1189900T3 (da) 2004-04-26
DE60007745T2 (de) 2005-03-10
EP1189900B1 (de) 2004-01-14
UY26226A1 (es) 2001-01-31
JP5248647B2 (ja) 2013-07-31
CA2376949A1 (en) 2001-01-11
WO2001002392A1 (en) 2001-01-11

Similar Documents

Publication Publication Date Title
DE60007745D1 (de) Heterocyclische aminopyrrolidon-derivate als melatonergene wirkstoffe
DE60110262D1 (de) Thiazol und oxazol-derivate als aktivatoren von menschlichen peroxisom proliferator aktivierten rezeptoren
DE60020812D1 (de) Heteroaryl-substituierte chinolin-2-on derivate verwendbar als antikrebsmittel
TR199901674T2 (de)
TR200201364T2 (tr) Yeni bileşikler.
DE60140456D1 (de) Aza heterocyclische derivate und ihre therapeutische verwendung
CO5200832A1 (es) Derivados de acidos heterociclicos, o una sal farmaceuticamente aceptable de los mismos, que son agentes antidiabeticos y antiobesidad
TR199800436A2 (xx) Primidin t�revlerinin kanserin �nlenmesi i�in kullan�lmas�.
DE60018372D1 (de) Oralzusammensetzung als mikroemulsion von silybin
SE9702773D0 (sv) Novel compounds
DE69929463D1 (de) Polyhydroxylierte heterocyclische derivate als antikoagulanten
ATE300543T1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
TR199903277T2 (xx) Benzimidazol t�revleri.
ES2110260T3 (es) Androstenonas.
ATE275143T1 (de) Verbindungen
TR200200125T2 (tr) Yeni aminotiyazol türevleri, bunların hazırlanması ve bunları içeren farmasötik kompozisyonlar.
DE60112960D1 (de) Kondensierte pyridoindolderivate
YU44301A (sh) 5ht1 antagonisti za antidepresantnu terapiju
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
ATE337320T1 (de) Indolderivate als pde5-inhibitoren
ATE273985T1 (de) Ruthenium (ii) verbindungen in der krebsbehandlung
ATE153657T1 (de) Cyclische benzylamino-, benzylamido- und benzylimido derivate als antipsychotische wirkstoffe
AR021094A1 (es) Compuestos heterociclicos inhibidores de la fosfodiesterasa iv y su uso para el tratamiento de enfermedades inflamatorias
CO5261576A1 (es) Compuestos
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1189900

Country of ref document: EP